Detalhe da pesquisa
1.
Small cell lung cancer: past, present, and future.
Curr Oncol Rep
; 12(5): 327-34, 2010 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-20632219
2.
New treatment strategies in patients with advanced non-small-cell lung cancer and performance status 2.
Clin Lung Cancer
; 9(6): 326-30, 2008 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-19073514
3.
Randomized phase 2 study of tivantinib plus erlotinib versus single-agent chemotherapy in previously treated KRAS mutant advanced non-small cell lung cancer.
Lung Cancer
; 117: 44-49, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29496255
4.
Should health-related quality of life be measured in cancer symptom management clinical trials? Lessons learned using the functional assessment of cancer therapy.
J Natl Cancer Inst Monogr
; (37): 53-60, 2007.
Artigo
em Inglês
| MEDLINE | ID: mdl-17951232
5.
The evolving role of cetuximab in non-small cell lung cancer.
Clin Cancer Res
; 12(14 Pt 2): 4432s-4435s, 2006 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-16857823
6.
Single-agent versus combination chemotherapy in advanced non-small-cell lung cancer: the cancer and leukemia group B (study 9730).
J Clin Oncol
; 23(1): 190-6, 2005 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15625373
7.
Topotecan therapy in patients with relapsed small-cell lung cancer and poor performance status.
Clin Lung Cancer
; 8(2): 130-4, 2006 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-17026814
8.
Optimizing Treatment Risk and Benefit for Elderly Patients With Advanced Non-Small-Cell Lung Cancer: The Right Treatment for the Right Patient.
J Clin Oncol
; 34(13): 1438-42, 2016 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27001591
9.
Treatment of Elderly Patients With Non-Small-Cell Lung Cancer: Results of an International Expert Panel Meeting of the Italian Association of Thoracic Oncology.
Clin Lung Cancer
; 16(5): 325-33, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25862554
10.
Role of Chemoradiotherapy in Elderly Patients With Limited-Stage Small-Cell Lung Cancer.
J Clin Oncol
; 33(36): 4240-6, 2015 Dec 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-26481366
11.
Treatment of patients with advanced lung cancer and poor performance status.
Clin Lung Cancer
; 6 Suppl 2: S71-4, 2004 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-15638962
12.
Treatment of advanced non-small-cell lung cancer in special populations.
Oncology (Williston Park)
; 18(10): 1321-5; discussion 1326, 1329-33, 2004 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-15526837
13.
Stereotactic body radiotherapy in patients with stage I non-small-cell lung cancer aged 75 years and older: retrospective results from a multicenter consortium.
Clin Lung Cancer
; 14(4): 446-51, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23660522
14.
Randomized phase III trial of single-agent pemetrexed versus carboplatin and pemetrexed in patients with advanced non-small-cell lung cancer and Eastern Cooperative Oncology Group performance status of 2.
J Clin Oncol
; 31(23): 2849-53, 2013 Aug 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-23775961
15.
Summary statement: novel agents in the treatment of lung cancer: advances in epidermal growth factor receptor-targeted agents.
Clin Cancer Res
; 12(14 Pt 2): 4365s-4371s, 2006 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-16857812
16.
Accrual to National Cancer Institute-sponsored non-small-cell lung cancer trials: insights and contributions from the CCOP program.
Clin Lung Cancer
; 10(6): 410-3, 2009 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-19900858
17.
American Society of Clinical Oncology perspective: Raising the bar for clinical trials by defining clinically meaningful outcomes.
J Clin Oncol
; 32(12): 1277-80, 2014 Apr 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-24638016
18.
New horizons in chemotherapy: platforms for combinations in first-line advanced non-small cell lung cancer.
J Thorac Oncol
; 3(6 Suppl 2): S171-4, 2008 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-18520305
19.
Prevalence of poor performance status in lung cancer patients: implications for research.
J Thorac Oncol
; 3(2): 125-9, 2008 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-18303431
20.
Summary statement novel agents in the treatment of lung cancer: Fifth Cambridge Conference assessing opportunities for combination therapy.
J Thorac Oncol
; 3(6 Suppl 2): S107-12, 2008 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-18520291